Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype–phenotype expression
Christos Paliouras, Georgios Aperis, Foteini Lamprianou, Giorgos Ntetskas, Konstantinos Roufas, Polichronis Alivanis
10.1016/j.nefroe.2015.09.009
Fabry disease as a trigger of immune-mediated glomerular disease: Clinical hypotheses and literature review
Javier Martínez de Victoria Carazo, Haylen Marin, Francisco Javier De la Hera Fernández, Carlos Mañero Rodríguez, César Ramírez Tortosa, José Luís Callejas Rubio
10.1016/j.nefroe.2025.04.010
Podocyturia in pediatric patients with Fabry disease
Miguel Liern, Anabella Collazo, Maylin Valencia, Alejandro Fainboin, Lorena Isse, Cristian Costales-Collaguazo, Federico Ochoa, Graciela Vallejo, Elsa Zotta
10.1016/j.nefroe.2019.03.001